ESTRING for Atrophic vulvovaginitis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where ESTRING was used for Atrophic vulvovaginitis.
Most Reported Side Effects for ESTRING
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product quality issue | 18 | 15.8% | 0 | 0 |
| Drug ineffective | 17 | 14.9% | 0 | 0 |
| Vulvovaginal discomfort | 15 | 13.2% | 0 | 0 |
| Vulvovaginal pain | 9 | 7.9% | 0 | 0 |
| Fungal infection | 8 | 7.0% | 0 | 0 |
| Vaginal odour | 7 | 6.1% | 0 | 0 |
| Vulvovaginal burning sensation | 6 | 5.3% | 0 | 0 |
| Vulvovaginal mycotic infection | 6 | 5.3% | 0 | 0 |
| Malaise | 5 | 4.4% | 0 | 0 |
| Muscle spasms | 5 | 4.4% | 0 | 0 |
| Vaginal discharge | 5 | 4.4% | 0 | 0 |
| Vulvovaginal pruritus | 5 | 4.4% | 0 | 0 |
Other Indications for ESTRING
Other Drugs Used for Atrophic vulvovaginitis
ESTRADIOL (1,139)
ESTROGENS, CONJUGATED (483)
PRASTERONE (214)
OSPEMIFENE (169)
OSPHENA (25)
PREMARIN (16)
ESTRADIOL\NORETHINDRONE (11)
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE (8)
ESTRIOL (6)
DUPILUMAB (5)